Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
101.28
(
-0.25%
)
Bitcoin
77,814.96
(
-1.07%
)
News Focus
News Focus
Post# of 257443
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122886
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 173397

Tuesday, 08/12/2014 11:05:54 AM

Tuesday, August 12, 2014 11:05:54 AM

Post# of 257443
VRTX will discontinue US sales of Incivek in October:

http://blogs.wsj.com/pharmalot/2014/08/12/from-riches-to-rags-vertex-discontinues-incivek-as-sales-evaporate/

Three years after being heralded as the fastest drug launch ever and quickly racking up $1 billion in sales, the Incivek hepatitis C treatment will be discontinued this coming October by Vertex Pharmaceuticals.

“This decision has been taken in view of available alternative treatments and the diminishing market demand for Incivek,” Vertex wrote in an Aug. 11 letter to health care providers. A copy was obtained by Pharmalot.

No discussion necessary.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today